Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Actinium Signs Cooperative Research and Development Agreement with National Cancer Institute
Actinium Pharmaceuticals, a leader in the development of targeted radiotherapies, have announced that it has […]
Ultima Genomics and Integrated DNA Technologies to Enable Application Portfolio on Ultima Sequencing Platforms
Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, has announced a […]
Halozyme Appoints Barbara Duncan to its Board of Directors
Halozyme Therapeutics today announced the appointment of Barbara Duncan to its Board of Directors. Ms. Duncan brings more […]
Dianosic Raises €4.7M to Bring Treatment for Chronic Rhinitis into Clinical Trial
Dianosic, a deeptech company specializing in the development of innovative solutions for the treatment of […]
Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform
As part of a shared commitment to bring better solutions for people suffering from depression, […]
Mihir Patel Joins Cambia Health Solutions as Chief Pharmacy Officer
Cambia Health Solutions has named Mihir Patel, Pharm.D., RPh, as its Chief Pharmacy Officer. In this […]
Chong Kun Dang Pharm and Synaffix Enter a Licensing Agreement
Chong Kun Dang Pharm (CKD), a global pharmaceutical company based in South Korea, and Synaffix […]
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]
Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe
Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more